Xcout Intel
Moleculera Labs competitors & alternatives
The 12 closest competitors and alternatives to Moleculera Labs among biotechnology companies — ranked by similarity to what Moleculera Labs actually does, not by market-cap band.
Subscribe to see Moleculera Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Moleculera Labs
Moleculera BioSciences is a precision medicine company dedicated to transforming patient care. The company develops next-generation diagnostic and predictive treatment algorithms for neurological and psychiatric conditions.
Moleculera Labs at a glance
Moleculera Labs is a biotechnology company headquartered in United States. It has raised at least $2.9M across the 2 funding rounds on record. Its most recent funding round raised $1.1M in May 2015. Xcout tracks 6 named people at Moleculera Labs, including Fred Hiller (Chief Financial Officer (Consultant)).
Moleculera Labs leadership
- Fred HillerChief Financial Officer (Consultant)
- Craig ShimasakiCo-Founder, President and CEO
- Madeleine CunninghamCo-Founder, Chief Scientific Officer (Consultant)
- James ApplemanVP Clinical Research & Development
- Joseph M. QuashnockClinical Laboratory Director
- Sean McCormickDirector of Medical Affairs (Consultant)
Moleculera Labs funding rounds
At least $2.9M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $1.1M | 2 named | |
| — | $1.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Moleculera Labs competitors
Ranked by semantic similarity — how close each company is to Moleculera Labs by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Genetika Plus (now known as NeuroKaire) focuses on transforming depression medication selection by addressing conditions like depression affecting millions worldwide, and collaborates on biopharma trials.
Similar biotechnology company
Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.
Diagnostics & Genetic Testing
Athena Diagnostics provides specialized diagnostic and genetic testing services focusing on neurological diseases, neuromuscular disorders, and developmental disorders such as Alzheimer's disease and muscular dystrophy. The company serves patients and healthcare providers by offering test catalogs, sample collection kits, requisition resources, and billing support.
Similar biotechnology company
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Genomics and Biotechnology
Mapmygenome is a molecular diagnostics company that provides personalized DNA, microbiome, and epigenome testing services for health and wellness.
Biotech
Centogene provides precision medicine solutions through advanced diagnostics, multiomic testing, and bioinformatics platforms. The company serves physicians, patients, and pharmaceutical partners by offering genomic sequencing, biomarker testing, and data-driven insights to accelerate rare disease diagnosis, drug discovery, and personalized therapies.
Life Sciences
Clarified Precision Medicine is a healthcare company headquartered in San Francisco, California, focused on precision medicine solutions.
Biotech
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
Similar biotechnology company
Mercy BioAnalytics, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Waltham, Massachusetts. The company is dedicated to developing early diagnostics and detection technologies.
Biotechnology & Medical Laboratories
Revna Biosciences is a precision medicine and clinical laboratory company based in Accra, Ghana, offering advanced diagnostics, genomic testing, biobanking, and clinical research support. It serves patients, healthcare providers, medical researchers, and life sciences organizations with internationally accredited testing services.
Biotech
MultiplexDX is an innovative biotech corporation that brings revolutionary technologies to the market of personalized molecular diagnostics. The company is entirely situated and headquartered at Comenius University Science Park in Bratislava, Slovakia, while also maintaining a US site near the NIH and FDA.
Medical - Diagnostics & Research
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Moleculera Labs and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Moleculera Labsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →